Yunxiang Zhou

3.0k total citations · 1 hit paper
43 papers, 2.1k citations indexed

About

Yunxiang Zhou is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yunxiang Zhou has authored 43 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yunxiang Zhou's work include Immune cells in cancer (5 papers), Anesthesia and Neurotoxicity Research (4 papers) and Ferroptosis and cancer prognosis (3 papers). Yunxiang Zhou is often cited by papers focused on Immune cells in cancer (5 papers), Anesthesia and Neurotoxicity Research (4 papers) and Ferroptosis and cancer prognosis (3 papers). Yunxiang Zhou collaborates with scholars based in China, United States and United Kingdom. Yunxiang Zhou's co-authors include Anwen Shao, Yongchuan Deng, Yihan Yao, Yali Wang, Shijie Wu, Yanyan Xu, Jianmin Zhang, Lihong Liu, Qiang Chen and Jianmin Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Neurochemistry.

In The Last Decade

Yunxiang Zhou

40 papers receiving 2.0k citations

Hit Papers

Nanoparticle-Based Drug D... 2020 2026 2022 2024 2020 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yunxiang Zhou China 20 784 492 468 276 245 43 2.1k
Yihan Yao China 13 710 0.9× 469 1.0× 479 1.0× 286 1.0× 255 1.0× 35 1.8k
Yongchuan Deng China 24 914 1.2× 505 1.0× 498 1.1× 498 1.8× 247 1.0× 53 2.4k
Yi Feng China 29 1.1k 1.4× 249 0.5× 358 0.8× 335 1.2× 183 0.7× 92 2.2k
Xiaoying Ying China 35 1.0k 1.3× 804 1.6× 857 1.8× 180 0.7× 210 0.9× 71 3.1k
Zhonglian Cao China 26 934 1.2× 373 0.8× 549 1.2× 212 0.8× 271 1.1× 53 2.1k
Yunyun Xu China 23 936 1.2× 386 0.8× 470 1.0× 510 1.8× 435 1.8× 78 2.7k
Wei Xie China 29 1.2k 1.5× 399 0.8× 1.1k 2.2× 295 1.1× 271 1.1× 78 2.7k
Qing Lin China 28 2.1k 2.6× 414 0.8× 451 1.0× 295 1.1× 372 1.5× 79 3.5k
Lanlan Li China 25 718 0.9× 366 0.7× 606 1.3× 101 0.4× 340 1.4× 71 2.2k
Ran Tian China 24 1.0k 1.3× 384 0.8× 460 1.0× 320 1.2× 223 0.9× 40 1.9k

Countries citing papers authored by Yunxiang Zhou

Since Specialization
Citations

This map shows the geographic impact of Yunxiang Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunxiang Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunxiang Zhou more than expected).

Fields of papers citing papers by Yunxiang Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunxiang Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunxiang Zhou. The network helps show where Yunxiang Zhou may publish in the future.

Co-authorship network of co-authors of Yunxiang Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yunxiang Zhou. A scholar is included among the top collaborators of Yunxiang Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunxiang Zhou. Yunxiang Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Zhengfang, Kaiyue Wang, Yunxiang Zhou, et al.. (2024). Why does HER2-positive breast cancer metastasize to the brain and what can we do about it?. Critical Reviews in Oncology/Hematology. 195. 104269–104269. 3 indexed citations
2.
Luo, Xu, Rui Wang, Yunxiang Zhou, & Wen Xie. (2024). The relationship between emotional disorders and heart rate variability: A Mendelian randomization study. PLoS ONE. 19(3). e0298998–e0298998. 1 indexed citations
3.
Zhou, Yunxiang, et al.. (2023). Pathologic complete response of hepatoid adenocarcinoma of the stomach after chemo-immunotherapy: A rare case report and literature review. Frontiers in Surgery. 10. 1133335–1133335. 6 indexed citations
4.
Zhou, Yunxiang, Kexin Liu, Yali Wang, et al.. (2023). Predictive Significance of Systemic Immune-Inflammation Index in Patients with Breast Cancer: A Retrospective Cohort Study. OncoTargets and Therapy. Volume 16. 939–960. 13 indexed citations
6.
Zhou, Zihan, Yunxiang Zhou, Peiqin Chen, et al.. (2022). A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration. Frontiers in Immunology. 13. 1023349–1023349. 12 indexed citations
7.
Wu, Shijie, Huihui Chen, Lu Shen, et al.. (2022). Functional assessment of missense variants of uncertain significance in the cancer susceptibility gene PALB2. npj Breast Cancer. 8(1). 86–86. 2 indexed citations
8.
Zhou, Yunxiang, Yali Wang, Hailong Chen, et al.. (2021). Immuno-oncology: are TAM receptors in glioblastoma friends or foes?. Cell Communication and Signaling. 19(1). 11–11. 11 indexed citations
9.
Zhou, Yunxiang, Anwen Shao, Yihan Yao, et al.. (2020). Dual roles of astrocytes in plasticity and reconstruction after traumatic brain injury. Cell Communication and Signaling. 18(1). 62–62. 139 indexed citations
10.
Wang, Xiaoyu, Yuanjian Fang, Yunxiang Zhou, et al.. (2020). SDF-1α/MicroRNA-134 Axis Regulates Nonfunctioning Pituitary Neuroendocrine Tumor Growth via Targeting VEGFA. Frontiers in Endocrinology. 11. 566761–566761. 9 indexed citations
11.
Yang, Linglin, Yunxiang Zhou, Honglei Jia, et al.. (2020). Affective Immunology: The Crosstalk Between Microglia and Astrocytes Plays Key Role?. Frontiers in Immunology. 11. 1818–1818. 46 indexed citations
12.
Zhou, Yunxiang, Lihong Liu, Sifeng Tao, et al.. (2020). Parthanatos and its associated components: Promising therapeutic targets for cancer. Pharmacological Research. 163. 105299–105299. 98 indexed citations
13.
Zhou, Yunxiang, et al.. (2020). Will Sirtuins Be Promising Therapeutic Targets for TBI and Associated Neurodegenerative Diseases?. Frontiers in Neuroscience. 14. 791–791. 21 indexed citations
14.
Zhou, Yunxiang, Yihan Yao, Lesang Shen, et al.. (2020). Osteopontin as a candidate of therapeutic application for the acute brain injury. Journal of Cellular and Molecular Medicine. 24(16). 8918–8929. 32 indexed citations
15.
Zhou, Yunxiang, et al.. (2020). Molecular hydrogen: A potential radioprotective agent. Biomedicine & Pharmacotherapy. 130. 110589–110589. 30 indexed citations
16.
Zhou, Yunxiang, Qiang Chen, Yi Luo, et al.. (2020). Dysfunction of the neurovascular unit in diabetes-related neurodegeneration. Biomedicine & Pharmacotherapy. 131. 110656–110656. 26 indexed citations
17.
Zhou, Yunxiang, Anwen Shao, Weilin Xu, Haijian Wu, & Yongchuan Deng. (2019). Advance of Stem Cell Treatment for Traumatic Brain Injury. Frontiers in Cellular Neuroscience. 13. 301–301. 56 indexed citations
18.
Tian, Wei, et al.. (2019). Changes in lipid profiles during and after (neo)adjuvant chemotherapy in women with early-stage breast cancer: A retrospective study. PLoS ONE. 14(8). e0221866–e0221866. 38 indexed citations
19.
Tian, Wei, et al.. (2018). Ovarian metastasis from breast cancer: a comprehensive review. Clinical & Translational Oncology. 21(7). 819–827. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026